Psychopathological symptoms of depression in Parkinson's disease compared to major depression

Psychopathology

Volumn 36, Issue 5, 2003, Pages 221-225

  Merschdorf, U ^a   Berg, D ^a   Csoti, I ^b   Fornadi, F ^b   Merz, B ^a   Naumann, M ^a   Becker, G ^c   Supprian, T ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Gertrudis Hospital   (Germany)

^c NONE

Author keywords

Major depression; Parkinson's disease; Psychopathology

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; FLUVOXAMINE; HYPERICUM EXTRACT; MAPROTILINE; MIRTAZAPINE; NORTRIPTYLINE; REBOXETINE; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ANHEDONIA; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DELUSION; DEPRESSION; DISEASE SEVERITY; FEMALE; GUILT; HUMAN; IRRITABILITY; MAJOR DEPRESSION; MALE; MOOD DISORDER; PARKINSON DISEASE; RESTLESSNESS; SUICIDE ATTEMPT; THOUGHT DISORDER;

AFFECT; AGED; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SUICIDE, ATTEMPTED;

EID: 0142218852     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073446     Document Type: Article

References (46)

1. Schiffer RB, Kurlan R, Rubin A, Boer S: Evidence for atypical depression in Parkinson's disease. Am J Psychiatry 1988;145:1020-1022.
2. Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ: Depressive symptoms in Parkinson's disease: A comparison with disabled control subjects. J Geriatr Psychiatry Neurol 1990;3:3-9.
3. Cummings JL: Depression in Parkinson's disease: A review. Am J Psychiatry 1992;149:443-454.
4. Menza MA, Robertson-Hoffman DE, Bonapace AS: Parkinson's disease and anxiety. Biol Psychiatry 1993;34:465-470.
5. Tandberg E, Larsen JP, Aarsland D, Cummings JL: The occurrence of depression in Parkinson's disease. Arch Neurol 1996;53:175-179.
6. Stefanova N, Seppi K, Scherfler C, Puschban Z, Wenning GK: Depression in α-synucleinopathies: Prevalence, pathophysiology and treatment. J Neural Transm 2000;60:335-343.
7. Slaughter JR, Slaughter KA, Nichols D, Holmes SE, Martens MP: Prevalence, clinical manifestation, etiology and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001;13:187-196.
8. Gotham AM, Brown RG, Marsden CD: Depression in Parkinson's disease: A quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986;49:381-389.
9. Brown RG, MacCarthy B: Psychiatric morbidity in patients with Parkinson's disease. Psychol Med 1990;20:77-87.
10. Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starkstein SE: Cognitive function in major depression and Parkinson disease. Arch Neurol 1997;54:982-986.
11. Cantello R, Aguggia M, Gilli M, Delsedime M, Chiardo Dutin I, Ricco A, Mutani R: Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: Possible role of the 'hedonic' dopamine synapse. J Neurol Neurosurg Psychiatry 1989;52:724-731.
12. Becker G, Struck U, Bogdahn U, Becker T: Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 1994;55:75-84.
13. Becker G, Becker T, Struck M, Lindner A, Burzer K, Retz W, Bogdahn U, Beckmann H: Reduced echogenicity of brainstem raphe specific to unipolar depression: A transcranial color-coded real-time sonography study. Biol Psychiatry 1995;38:180-184.
14. Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, Lindner A, Reichmann H, Riederer P, Beckman H, Reiners K: Parkinson's disease and depression: Evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 1997;63:590-596.
15. Berg D, Supprian T, Hofmann E, Zeiler B, Jäger A, Lange KW, Reiners K, Becker T, Becker G: Depression in Parkinson's disease: Brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 1999;246:1186-1193.
16. Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RS, Dolan RJ: Depression in Parkinson's disease - A positron emission study. Br J Psychiatry 1994;165:333-339.
17. Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Muller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP: A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Mol Psychiatry 1996;1:453-460.
18. Gutierrez B, Pintor L, Gasto C, Rosa A, Bertranpetit J, Vieta E, Fananas L: Variability in the serotonin transporter gene and increased risk for major depression with melancholia. Hum Genet 1998;103:319-322.
19. Lesch KP, Mössner R: Genetically driven variation in serotonin uptake: Is there a link to affective spectrum, neurodevelopmental and neurodegenerative disorders. Biol Psychiatry 1998;44:179-192.
20. Mössner R, Henneberg A, Schmitt A, Syagailo YV, Grässle M, Hennig T, Simantov R, Gerlach M, Riederer P, Lesch KP: Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol Psychiatry 2001;6:350-352.
21. Chia LG, Cheng LJ, Chuo LJ, Cheng FC, Cu JS: Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson's disease. J Neurol Sci 1995;133:73-78.
22. Leonard BE: The role of noradrenalin in depression: A review. J Psychopharmacol 1997;11:39-47.
23. Schildkraut JJ: Neuropharmacology of affective disorders. Annu Rev Psychopharmacol 1973;13:427-454.
24. Goodwin FK, Post RM, Dunner DL, Gordon EK: Cerebrospinal fluid amine metabolites in affective illness. The probenecid technique. Am J Psychiatry 1973;130:73-79.
25. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, APA, 1995.
26. Ward D, Gibb WR: Research criteria for Parkinson's disease; in Streifler MB, Korzyn AD, Melamed E, Youdim MBH (eds): Parkinson's Disease: Anatomy, Pathology and Therapy. Adv Neurol 1990;53:245-249
27. Fahn S, Elton RL and Members of the UPDRS Development Committee: Unified Parkinson's disease rating scale; in Fahn S, Marsden CD, Goldstein M et al (eds): Recent Developments in Parkinson's Disease. II. New York, Macmillan, 1987, pp 153-163.
28. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
29. Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW: The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry 2000;15:644-649.
30. Beck AT, Ward CJ, Mendelsohn M, Mock H, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
31. Richter P, Werner J, Heerlein A, Kraus A, Sauer H: On the validity of the Beck Depression Inventory. Psychopathology 1998;31:160-168.
32. Leentjens AF, Verhey FR, Luijckx GJ, Troost J: The validity of the Beck Depression Inventory as a screening instrument for depression in patients with Parkinson's disease. Mov Disord 2000;15:1221-1224.
33. Zerssen D, Köller DM: Die Befindlichkeitsskala. Manual. Weinheim, Beltz, 1976.
34. Overall JE, Hollister LE, Pichot P: Major psychiatric disorders: A four-dimensional model. Arch Gen Psychiatry 1967;16:146-151.
35. Collegium Internationale Psychiatriae Scalarum: Rating Scales for Psychiatry. Weinheim, Beltz, 1990.
36. Franz M, Lemke MR, Meyer T, Ulferts J, Puhl P, Snaith RP: Deutsche Version der Snaith-Hamilton Pleasure Scale. Fortschr Neurol Psychiatr 1998;66:407-413.
37. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG: A prospective longitudinal study of depression, cognitive decline and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:377-382.
38. Oertel WH, Höglinger GU, Caraceni T, Girotti F, Eichhorn T, Spottke AE, Krieg JC, Peowe W: Depression in Parkinson's disease. An update; in Calne D, Calne S (eds): Parkinson's Disease. Adv Neurol 2001;86:373-383.
39. Birkmayer W, Riederer P: Biological Aspects of Depression in Parkinson's Disease. Psychopathology 1986;19(suppl 2):58-61.
40. Baumann B, Danos P, Diekmann S, Bilau H, Gerecke N, Bernstein HG, Bogerts B: Postmortem analysis of noradrenergic and serotonergic brainstem systems in mood disorders. Eur Arch Psychiatry Clin Neurosci 1998;248(suppl 2):79.
41. Baumann B, Danos P, Krell D, Diekmann S, Wurthmann C, Bielau H, Bernstein HG, Bogerts B: Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology. J Affect Disord 1999;54:217-224.
42. Becker G, Berg D, Lesch KP, Becker T: Basal limbic system alteration in major depression: A hypothesis supported by transcranial sonography and MRI findings. Int J Neuropsychopharmacol 2001;4:21-31.
43. Brown RG, MacCarthy B, Gotham AM, Der RJ, Marsden CD: Depression and disability in Parkinson's disease: A follow-up study of 132 cases. Psychol Med 1988;18:49-55.
44. Henderson R, Kurlan R, Kersun J, Como P: Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992;4:257-264.
45. Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG: Depression in Parkinson's disease. J Nerv Ment Dis 1990;178:27-31.
46. Myslobodsky M, Lalonde FM, Hicks L: Are patients with Parkinson's disease suicidal? J Geriatr Psychiatry Neurol 2001;4:120-124.